Your one-stop Solution for MEDICAL LEARNING & UPDATES

hidoc_medibot hidoc_medibot

Today's Updates

This Week on NeurologyLive® — September 28, 2026 Isabella Ciccone, MPH

Published Date: 30 Sep 2026

Here's some of what is coming soon to NeurologyLive® this week.

Somnolence Risk, Short-Term Efficacy Drive VMAT2 Inhibitor Choice in Older Adults With Tardive Dyskinesia Isabella Ciccone, MPH

Published Date: 30 Sep 2026

In a discrete choice experiment, somnolence risk and short-term efficacy were the top factors driving vesicular monoamine transporter 2 inhibitor selection for tardive dyskinesia in patients aged 55 years and older.

FDA Approves Tavapadon for the Treatment of Parkinson Disease Isabella Ciccone, MPH

Published Date: 30 Sep 2026

FDA approves once-daily oral tavapadon for Parkinson disease, a first-in-class D1/D5 partial agonist that improves motor function and ON time, with key safety warnings.

Gefurulimab Cuts Hospitalizations, Sustains Response in Phase 3 PREVAIL Trial of Myasthenia Gravis Marco Meglio

Published Date: 30 Sep 2026

New PREVAIL trial analyses presented at the 2026 AANEM Annual Meeting showed gefurulimab reduced gMG-related hospitalizations and produced durable symptom and quality-of-life gains through one year.

SHIELD Trial Advances Combination Antiviral for Long COVID Marco Meglio

Published Date: 30 Sep 2026

PridCor Therapeutics is moving its phase 2 SHIELD trial of a combination antiviral regimen toward enrollment, building on case series data showing durable symptom improvement in long COVID.

Inebilizumab Shows Durable Benefit in MuSK+ Generalized Myasthenia Gravis at AANEM 2026 Marco Meglio

Published Date: 30 Sep 2026

New phase 3 MINT trial analyses presented at the 2026 AANEM Annual Meeting showed inebilizumab produced sustained improvement in MuSK-positive gMG regardless of time since diagnosis.

5 Nephrology Headlines You Missed in August 2026 Alex Hillenbrand

Published Date: 30 Sep 2026

A joint ESC/ERA guideline on universal CKD screening headlines August 2026's nephrology news, alongside new finerenone and sibeprenlimab trial data.

Targeting Gut Candida to Treat IBD, With Iliyan D. Iliev, PhD

Published Date: 30 Sep 2026

Targeting Gut Candida to Treat IBD, With Iliyan D. Iliev, PhD

Semaglutide 2 mg Escalation Tied to Lower MACE vs Tirzepatide Switch in T2D

Published Date: 30 Sep 2026

Semaglutide 2 mg Escalation Tied to Lower MACE vs Tirzepatide Switch in T2D

The Present and Future of Precision Medicine in Dermatology, With Peter Lio, MD Peter Lio, MD

Published Date: 30 Sep 2026

Peter Lio, MD, discusses why precision medicine has advanced further in psoriasis than atopic dermatitis, and what oncology can teach dermatology.

Knowledge Hub

Oncology

Molecular Glues for Solid Tumors: Mechanisms, Clinical Evidence, and Therapeutic Potential 

Comprehensive review of molecular glues in solid tumor therapy, covering mechanisms, clinical evidence, and future directions.

Oncology

Oncologic Emergencies Requiring Intensive Care: A Comprehensive Review 

Comprehensive review of oncologic emergencies in intensive care, with evidence-based guidelines for clinicians.

Oncology

Pathophysiology of Tumor-Stroma Mechanical Interactions 

Comprehensive review of the mechanical interactions between tumor cells and stroma, with clinical and therapeutic implications.

Oncology

RIBOTAC Therapy for Oncogenic RNA: A Paradigm Shift in Targeted Cancer Treatment 

Comprehensive review of RIBOTAC therapy targeting oncogenic RNA in cancer treatment for medical professionals.

Oncology

Oncology Medication Safety Handoffs: Ensuring Continuity and Reducing Adverse Events in Cancer Care

Oncology

Oncology Communication Training for Difficult Conversations

Oncology

Risk Assessment of Cancer-Associated Endocrine Disorders

KOL Videos

Hidoc Dr| Hidoc- US| Hidoc - Doctor Netwoking Platform| Educational resource for HCPs

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V

Dr. Harish P and 1 more

Hidoc Dr| Hidoc- US| Hidoc - Doctor Netwoking Platform| Educational resource for HCPs

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV

Dr. Vijay Agarwal and 1 more

Hidoc Dr| Hidoc- US| Hidoc - Doctor Netwoking Platform| Educational resource for HCPs

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session

Dr Suvir Singh

Hidoc Dr| Hidoc- US| Hidoc - Doctor Netwoking Platform| Educational resource for HCPs

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III

Dr. Harish P and 1 more

Hidoc Dr| Hidoc- US| Hidoc - Doctor Netwoking Platform| Educational resource for HCPs

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion

Dr Suvir Singh

Hidoc Dr| Hidoc- US| Hidoc - Doctor Netwoking Platform| Educational resource for HCPs

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II

Dr Vijay Agarwal and 1 more

Hidoc Dr| Hidoc- US| Hidoc - Doctor Netwoking Platform| Educational resource for HCPs

An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion

Dr Suvir Singh

Hidoc Dr| Hidoc- US| Hidoc - Doctor Netwoking Platform| Educational resource for HCPs

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII

Dr. Todd Bauer and 1 more

Hidoc Dr| Hidoc- US| Hidoc - Doctor Netwoking Platform| Educational resource for HCPs

Current Scenario of Cancer- Q&A Session to Close the Gap Part II

Dr. Poonam Patil and 1 more

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot